Fujian Aonong Biological Technology Group Incorporation Ltd (603363) — Working Capital to Net Assets Ratio
Fujian Aonong Biological Technology Group Incorporation Ltd (603363) has a Working Capital to Net Assets ratio of 2.0% as of September 2025. Working capital of CN¥75.29 Million (current assets of CN¥3.52 Billion minus current liabilities of CN¥3.45 Billion) is measured against net assets of CN¥3.79 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see Fujian Aonong Biological Technology Grou total assets.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Fujian Aonong Biological Technology Group Incorporation Ltd Working Capital to Net Assets (2013–2024)
This chart shows how Fujian Aonong Biological Technology Group Incorporation Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 2.0%, reflecting working capital of CN¥75.29 Million against net assets of CN¥3.79 Billion CNY. Explore 603363 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Working Capital to Net Assets for Fujian Aonong Biological Technology Group Incorporation Ltd (2013–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Fujian Aonong Biological Technology Group Incorporation Ltd from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read Fujian Aonong Biological Technology Grou debt and liabilities for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -29.9% | CN¥-914.89 Million | CN¥3.06 Billion | CN¥3.70 Billion | CN¥4.61 Billion | ▼ -1733.0 pp |
| 2023 | 1703.1% | CN¥-8.57 Billion | CN¥-503.22 Million | CN¥2.79 Billion | CN¥11.36 Billion | ▲ +1893.4 pp |
| 2022 | -190.3% | CN¥-6.53 Billion | CN¥3.43 Billion | CN¥5.12 Billion | CN¥11.65 Billion | ▲ +76.7 pp |
| 2021 | -266.9% | CN¥-5.85 Billion | CN¥2.19 Billion | CN¥4.26 Billion | CN¥10.12 Billion | ▼ -197.1 pp |
| 2020 | -69.8% | CN¥-2.72 Billion | CN¥3.90 Billion | CN¥3.52 Billion | CN¥6.25 Billion | ▲ +75.7 pp |
| 2019 | -145.5% | CN¥-1.87 Billion | CN¥1.28 Billion | CN¥1.51 Billion | CN¥3.38 Billion | ▼ -70.6 pp |
| 2018 | -74.9% | CN¥-755.55 Million | CN¥1.01 Billion | CN¥1.23 Billion | CN¥1.98 Billion | ▼ -69.6 pp |
| 2017 | -5.2% | CN¥-50.64 Million | CN¥965.55 Million | CN¥1.18 Billion | CN¥1.23 Billion | ▲ +19.9 pp |
| 2016 | -25.2% | CN¥-149.39 Million | CN¥593.75 Million | CN¥801.71 Million | CN¥951.10 Million | ▲ +1.8 pp |
| 2015 | -27.0% | CN¥-120.24 Million | CN¥445.39 Million | CN¥751.31 Million | CN¥871.56 Million | ▲ +39.7 pp |
| 2014 | -66.7% | CN¥-143.45 Million | CN¥214.94 Million | CN¥554.69 Million | CN¥698.14 Million | ▲ +29.0 pp |
| 2013 | -95.8% | CN¥-101.85 Million | CN¥106.35 Million | CN¥502.24 Million | CN¥604.09 Million | — |